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Abstract—While we once thought of cancer as single monolithic
diseases affecting a specific organ site, we now understand
that there are many subtypes of cancer defined by unique
patterns of gene mutations. These gene mutational data, which
can be more reliably obtained than gene expression data, help
to determine how the subtypes develop, evolve, and respond
to therapies. Different from dense continuous-value gene ex-
pression data, which most existing cancer subtype discovery
algorithms use, somatic mutational data are extremely sparse
and heterogeneous, because there are less than 0.5% mutated
genes in discrete value 1/0 out of 20,000 human protein-coding
genes, and identical mutated genes are rarely shared by cancer
patients.
Our focus is to search for cancer subtypes from extremely
sparse and high dimensional gene mutational data in discrete
1 and 0 values using unsupervised learning. We propose a new
network-based distance metric. We project cancer patients’
mutational profile into their gene network structure and mea-
sure the distance between two patients using the similarity
between genes and between the gene vertexes of the patients
in the network. Experimental results in synthetic data and
real-world data show that our approach outperforms the top
competitors in cancer subtype discovery. Furthermore, our
approach can identify cancer subtypes that cannot be detected
by other clustering algorithms in real cancer data.
1. Introduction
Identifying cancer subtypes is essential for a wide range
of applications including better understanding the biological
complexity of the disease and developing targeted, precision
medicine therapeutic interventions [1], [2]. Subtype discov-
ery is a fundamental yet unsolved problem in cancer analysis
as the presence of multiple subtypes can confound many
analyses [3], [4].
Gene mutational data, which can be more reliably ob-
tained than gene expression data, help to determine how the
subtypes develop, evolve, and respond to therapies [5], [6].
Different from dense continuous-value gene expression data,
which most existing cancer subtype discovery algorithms
use, somatic mutational data are extremely sparse and het-
erogeneous, because there are less than 0.5% mutated genes
out of 20,000 human protein-coding genes, and identical
mutated genes are rarely shared by cancer patients [7].
Clustering algorithms are often used for cancer subtype
discovery. The major barrier for clustering algorithms is how
to battle with extremely sparse and high dimensional gene
mutational data in discrete 1 and 0 values.
We propose a new network-based distance metric to
take advantage of the prior knowledge of gene regulator
networks. We project cancer patients’ mutational profile
into their gene network structure and measure the distance
between two patients using the similarity between genes and
between the gene vertexes of the patients in the network.
We introduce a novel metric to measure gene similarity that
fully utilizes network structures, and patient gene mutational
profiles are optimally aligned based on network structures.
Experimental results show that our approach outperforms
the top competitors in cancer subtype discovery using a
comprehensive set of evaluation metrics. Furthermore, our
approach can identify cancer subtypes with biological signif-
icance that cannot be detected by other clustering algorithms
in real cancer data.
Thus, our main contributions are as follows:
(1) Network-based distance metric: we propose a novel
distance metric to measure similarity between cancer pa-
tients using gene regulator networks.
(2) Effectiveness: Our approach outperforms state-of-
the-art algorithms in discovering cancer subtypes, and de-
tects biological significant cancer subtype that cannot be
identified by the top competitors from real cancer data.
Furthermore, our network-based distance metric can be
easily incorporated into any clustering algorithm with appli-
cation to data whose attributes have network structures.
Reproducibility: Our code is open-sources at
https://github.com/qiang2100/NetAP.
2. A Novel Network-based Distance Metric
We introduce a new approach of gene similarity and
patient similarity to compute the similarity between two pa-
tient profiles by incorporating gene interaction information
in gene networks.
Overview of our network-based distance metric. Even
if two patients do not have any mutations in common,
they are likely to belong to the same cluster when their
mutations reside in close network regions. The gene in-
teraciton network includes the relationship between genes,
where each node represents one gene. Take the example
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Figure 1. An illustration of three patients (p1, p2, and p3) with mutated
genes and their correspondent gene network. The total number of vertices
in this network is 30. The mutated genes of p1, p2 and p3 are marked in
green stars, red squares, and cyan diamonds, respectively. Although these
three patients do not share any common mutated genes, p1 and p2 are more
likely to belong to one subtype than p1 and p3, because the mutated genes
of p1 are closer to the mutated genes of p2 than p3.
of three patients with three mutated genes: p1=(8,10,11),
p2=(1,3,7), p3=(5,22,29), and one correspondent gene in-
teraction network. Because these patients do not share any
common mutated genes, the similarity among the three pa-
tients is zero using traditional distance metrics. However, if
we measure the mutated genes residing in a gene interaction
network after projecting three patients into the gene network
(see Figure 1), it is clear that p1 and p2 are more likely to
belong to one cluster (same cancer subtype) than p1 and p3,
because the mutated genes of p1 are biologically similar to
the mutated genes of p2 than p3.
Through independently projecting each patient into the
gene network, we transform the similarity between two
patients to the similarity of two sub-networks. This approach
has two advantages: (1) it reduces the dimensionality since
we only need consider these genes from the network; (2) two
patients sharing similar network regions will have higher
similarity than two patients not sharing similar network
regions. Our distance metric calculation includes two steps:
1) We need to compute the similarity between genes
using the gene network.
2) After projecting each patient into the gene network,
we need to match the vertices of two patients, and apply
our distance metric to compute the similarity between two
patients.
Gene Similarity. We first present how to compute the
similarity between individual node(gene) pairs according to
the gene network. Let sim(u, v) represent the similarity
between vertice u and vertice v. Since two patients are more
likely to belong to the same cluster when their mutations
share the similar network regions, the closer the distance
between two vertices in the network, the higher similarity
they have. The similarity between vertices can be calculated
with two cases: the similarity of a vertice with itself and the
similarity of different vertices. The pseudocode of comput-
ing the similarities between genes is described in Algorithm
1.
For the first case, we first assign 1 (lines 2 to 4) as a
initial value to the similarity of one vertex with itself. In
a typical approach, the similarity between a gene and itself
should be 1. However, in our new proposed distance metric,
the similarity between the same gene from two different
cancer patients is calculated based on the netwrok that the
gene resides. We will first compute the similarity between
other vertices, and then modify the value based on their
corresponding neighbors in order to distinguish the influence
of different vertices (see discussion for Equations 2, 3, and
4 later in this section).
If u and v have a direct connection in the gene network,
they are neighbors. The similarity between two vertices is
similar to the degree of closeness of relationship between
two vertices. For two different vertices, the similarity be-
tween two vertices should become smaller as the distance in-
creases. The closeness between two vertices are determined
by their number of neighbors. For two different vertices (u
and v), similarity can be calculated by finding the greatest
similar path from one vertex to another vertex.
At first, for two vertices that are adjacent, its initial vaule
are set using traditional approach (lines 5 to 7),
sim(u, v) =
| edge(u) | ∩ | edge(v) |
| edge(u) | ∪ | edge(v) | (1)
where edge(u) represents all edges of vertex u, and |
edge(u) | represents the number of u’s edges.
We will update the similarity between two vertices by
finding the greatest similar path using other vertices as
intermediate points along the way. We define a function
similarPath(i, j, k) that returns the greatest similar path
from i to j using vertices only from the set {1,2,...,k}
as intermediate points along the way. After defining this
function, our aim is to find the greatest similar path from
each i to each j using only vertices from 1 to k + 1 (lines
8 to 16). The greatest similar path of each pair of vertices
must be either (1) a path that only uses vertices in the set
{1,2,...,k}, or (2) a path that goes from i to k+1 and then
from k+1 to j. Consequently, we can define sim(i, j, k+1)
recursively: the base case is
similarPath(i, j, 0) = sim(i, j) (2)
and the recursive case is
similarPath(i, j, k + 1)
= max(similarPath(i, j, k), similarPath(i, k + 1, k)
× similarPath(k + 1, j, k))
(3)
Equation 3 ensures that the similarity between pair i and
j is always the greatest similar path.
The formula is similar to Floyd’s algorithm that can
be used for finding shortest paths in a weighted network
[8], [9]. In Floyd’s algorithm, it adds all the weights along
the path. In our method, we multiply them using Equation
3. The strategy computes similarPath(i, j, k) for all (i, j)
pairs for k = 1, then k = 2, until k = m, and we can find
the similar path for all (i, j) pairs using any intermediate
vertices. Finally, similarity between a vertex g and itself can
be updated as the sum of its similarity from all its neighbor’s
vertices in gene network (lines 17 to 19),
sim(g, g) =
∑
j∈neigh(g)
sim(g, j) (4)
Here, neigh(g) represents all neighbors of vertice g. The
underlying principle of Equation 4 is that the similarity
between a gene and itself in a densely connected network
is greater than a gene in a loosely connected network.
Algorithm 1 Gene similarity using gene network
1: Let sim be a m×m matrix that are initialized to zero
2: for each vertex g do
3: sim(g, g)← 1
4: end for
5: for each edge (u,v) do
6: sim(u, v)← Equation 1
7: end for
8: for k from 1 to m do
9: for i from 1 to m do
10: for j from 1 to m do
11: if sim(i, j) ≤ sim(i, k)× sim(k, j) then
12: sim(i, j)← sim(i, k)× sim(k, j)
13: end if
14: end for
15: end for
16: end for
17: for each vertex g do
18: sim(g, g)←∑j∈neigh(g) sim(g, j)
19: end for
The complexity of computing the similarity between
genes is O(m3), where m is the number of genes in gene
network. Note that in order to reduce the computational cost
of the above algorithm, a threshold can be set for sim(i, k)
(e.g., 1e-6 for this work) so that the dissimilarity between
two genes is filtered out and the algorithm can be accelerated
greatly.
Patient Similarity. After projecting each patient into the
gene network, we compute the similarity between two pa-
tients through their own mutated genes’s distance in the
network. To distinguish from the other metrics, we refer
to the distance metric as gene aligning’s similarity (GAS).
Let ri and rj be the representation of patient i and patient
j. We can think of ri as a set of vertices in gene network,
where ri,g = 1/(| ri |) is the weight of the vertex g of
patient i. Here, | ri | is the number of the vertices of patient
ri in gene network. The task of patient similarity is how
to optimally align the genes of patient i and patient j to
properly calculate the maximal similarity.
First, we measure the alignment between vertices ri and
rj by calculating the weight of vertices ri align to the
vertices rj through the gene network. Let T ∈ Rm×m be a
align matrix, where Tu,v represents how much the weight
of vertex u of ri matches to vertex v of rj , and m is the
number of genes in the gene network. Further, to match all
weights of ri into rj , the entire outgoing weight from vertex
u equals ri,u, namely
∑
v Tu,v = ri,u. Correspondingly,
the amount of incoming weight to vertex v must equal
rj,v , namely,
∑
u Tu,v = rj,v . At last, we can define the
similarity of two patients as the maximum cumulative cost
required to align from all vertices of one patient to the other
patient, namely,
∑
u,v Tu,vsim(u, v). Given the constraints,
the similarity between two patients can be solved using the
following linear programming,
max
T≥0
m∑
u,v
Tu,vsim(u, v)
such that :
m∑
v
Tu,v = ri,u ∀u ∈ {1, 2, ...,m} (5)
m∑
u
Tu,v = rj,v ∀v ∈ {1, 2, ...,m}
The above optimization is a special case of the Earth
Mover’s Distance [10], [11], a well-known transportation
problem for which specialized solvers have been developed
[12], [13]. The best average time complexity of solving the
GAS problem is O(m3logm), where m is the number of
all genes in the gene network [13]. To speed up the opti-
mization problem, we relax the GAS optimization problem
and remove one of the two constraints. Consequently, the
optimization becomes,
max
T≥0
m∑
u,v
Tu,vd(u, v) s.t.
m∑
v
Tu,v = ri,u∀u ∈ {1, 2, ...,m}
(6)
The optimal solution is the probability of each gene in
a patient is aligned to the most similar gene in the other
patient. The time complexity of GAS can be reduced to
O(mlogm).
Recall the earlier example of three patients in Figure 1.
The weight of each gene of each patient is 13 . For patient p1
and p2, the weight of gene 11 aligns to gene 3, the weight
of gene 10 aligns to gene 1, and the weight of gene 8 aligns
to gene 7. We note that GAS agrees with our intuition, and
”aligns” genes to nearby genes. Consequently, the similarity
of p1 and p2 (0.11) is significantly bigger than the similarity
of p1 and p3 (0.00694), although all of them do not share
one common mutated gene. The result meets our assumption
that p1 and p2 are more likely to belong to one subtype than
p1 and p3.
Cancer subtype discovery. The similarity matrix of patients
is used on cancer subtype discovery via Affinity Propagation
[14]. Affinity Propagation is a clustering algorithm that
takes as input measures of similarity between pairs of texts
and simultaneously considers all data points as potential
exemplars. The whole method is named as Network-based
Affinity Propagation (NetAP). The framework of NetAP is
shown in Figure 2.
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Figure 2. Framework of Network-based Affinity Propagation.
3. Experiment
The task of clustering cancer patients using tumor mu-
tation information is difficult. A real-world cancer dataset
typeically has hundreds of samples, but the number of gene
mutation features can be well above 15,000 as shown in
Table 1. Cancer is a complex disease. Two cancer patients
of the same cancer subtype may not share any common
mutated genes. Therefore, many clustering methods cannot
achieve good results if they calculate two samples’ distance
directly using the gene mutation feature. Cancer has highly
heterogeneous causes, and it is difficult to find a clear group
of genes to determine subtypes. In our empirical study,
we observe that AP is the strongest baseline clustering
algorithm even though it does not use gene network. A
possible explanation is that the power of belief-propagation
can better tune the centers of each cluster. Hence, in our
experiments we chose AP to integrate with gene interaction
networks for optimal performance. We evaluate our NetAP
algorithm using synthetic data and real-world data with
different focuses:
(1) Evaluation using Synthetic Data. How accurately
does NetAP detect cancer subtypes with respect to various
gene network structures? Does NetAP outperform the state-
of-the-art algorithms used for cancer subtype discovery?
(2) Performance using Real-World Data. Does NetAP
detect cancer subtypes that are clinically meaningful? What
is the impact of different gene networks on performance?
Can NetAP identify cancer subtypes that cannot be detected
by other clustering algorithms?
We implemented NetAP in Matlab1. All experiments
were conducted on a Windows machine with an Intel 437
2.9 GHz CPU and 8GB memory. Table 1 and Table 2
show the details of the real-world Uterine and Lung cancer
datasets and three gene interaction networks we used in our
experiments.
1. the source code can be downloaded at
https://github.com/qiang2100/NetAP
TABLE 1. SUMMARY OF UTERINE AND LUNG CANCERS
#: the number of patients, SIZE: the number of genes, AVG: the average
mutated genes of each patient
Dataset # SIZE AVG
Uterine 248 17968 612.96
Lung 304 15967 326.83
3.1. Dataset Information and Experiment Setup
Synthetic Data. To test the accuracy of our method,
we built a synthetic dataset to mirror the biological char-
acteristics of cancer and investigate the effectiveness of the
incorporation of gene interaction networks. We randomly
select four subnetwork modules from the Search Tool for
the Retrieval of Interacting Genes/Proteins (STRING) gene
interaction network [15], and yield 200 cancer patient sam-
ples with 50 samples per cancer subtype. For each sample,
we reassign a fraction of mutations to fall within its network
modules. Simultaneously, given an overlapping rate r (0.05
and 0.1), each sample has a probability r to select mutations
from other network modules. Here, the overlapping rate
0.05 or 0.1 indicates how strongly the network structure
is embedded in the data. Higher overlapping rate means a
larger number of genes are shared among different subtypes.
Real-world Data. High-grade uterine endometrial carci-
noma and lung adenocarcinoma somatic mutation data were
collected from the The Cancer Genome Atlas (TCGA) data
portal2. Only mutation data generated using the high-quality
Illumina GAIIx platfrom were saved for the following anal-
ysis, and patients with less 10 mutations were removed
for fair comparison with [7]. Patient mutation profiles are
constructed as binary vectors such that a bit is set to 1 if the
gene corresponding to that position in the vector is mutated
in that patient. We follow the same somatic mutation data
processing procedure as [2], [7].
Evaluation Metrics: The clustering results on real-
world data are evaluated using histological types provided
by the TCGA data. Five metrics are used to measure
the clustering performance: Normalized Mutual Information
(NMI), Rand Index (RI), Adjusted Rand Index (AR), Chi-
square test and P-Value, chosen based on established evalu-
ation criteria in the literature. NMI, RI and AR are widely
used to evaluate performance of clustering algorithms in
data mining and machine learning [16], [17]. Chi-square
test (Chi-Square) and P-Value are mostly used in statistics
and bioinformatics [18]. For NMI, RI, AR, and Chi-square,
a larger score indicates better clustering performance. For
p-value, a small p-value represents good clustering quality.
• Normalized Mutual Information (NMI) is a clus-
tering validation metric that effectively measures
the amount of statistical information shared by the
predicted cluster assignments and the ground truth,
independent of the absolute cluster label values. Two
patients are assigned to the same cluster if and only
if they are similar, thus clustering can be viewed as
a series of pair-wise decisions.
2. https://tcga-data.nci.nih.gov/tcga/
TABLE 2. SUMMARY OF GENE INTERACTION NETWORKS
Nodes Edges
PathwayCommons 14,355 (2814) 507,757 (33,757)
STRING 16,569 (12,233) 1,638,830 (164,034)
HumanNet 16,243 (7,949) 476,399 (47,641)
• Rand Index (RI) measures the percentage of clus-
tering decisions that are correct. Rand Index can be
adjusted for the chance grouping of elements, which
will result in one of its variants called Adjusted Rand
Index (AR). AR has a value between 0 and 1, and
RI can have negative values.
• Chi-squared test is used to determine whether there
is a significant difference between the expected clus-
ters and the observed clusters.
• P-Value can determine how significant clustering re-
sults are by performing a hypothesis test commonly
used in statistics.
Existing State-of-the-art Methods for comparison:
We compared our NetAP algorithm with Nonnegative Ma-
trix Factorization (NMF) [19], Latent Dirichlet Allocation
(LDA) [20], Affinity Propagation (AP) [14], and Network-
based stratification(NBS) [7]. NMF, LDA, and NBS are the
leading clustering algorithms on cancer subtype discovery.
AP has shown better performance on computational biology
tasks than K-means. We use the open-source MATLAB im-
plementation3 for NMF based on Euclidean distance. LDA
based on gibbs sampling is chosen as comparison4 [21] with
parameters α=0.1 and β=0.1. For AP, we use the ”apcluster”
package in R5. Based on empirical observation, Peason
correlation coefficient is chosen as the distance metric. The
source code of NBS is provided in Hofree et al. [7]. We set
parameter λ=0.9 for AP and NetAP.
Gene Interaction Network: To evaluate the impact of
different gene interaction network, three major gene interac-
tion databases are used: PathwayCommons [22], STRING
[15] and HumanNet [23]. PathwayCommons6 includes gene
interaction information extracted from multiple gene in-
teraction databases, and its focus is on physical protein-
protein interactions. We excluded all non-human genes and
interactions from the PathwayCommons network in our
experiments. STRING7 collects protein-protein interactions
from expression data analysis and medical literature using
text mining methods. HumanNet8 is built by a modified
Bayesian integration from multiple organisms. Only the top
10% interactions of STRING and HumanNet are used in our
experiments to reduce noise. Table 2 summarizes the number
of genes and interactions, and the numbers in parentheses
are specific for our experiments.
3. https://sites.google.com/site/nmftool/
4. http://psiexp.ss.uci.edu/research/programs˙data/toolbox.htm
5. https://cran.r-project.org/web/packages/apcluster/index.html
6. www.pathwaycommons.org/pc/
7. www.string-db.org/
8. www.functionalnet.org/humannet/
Figure 3. Performance of all methods with two different overlapping
rates(0.05 and 0.1) on synthetic data). NetAP is our proposed method.
For P-value metric, the smaller the better. For other metrics, the larger the
better.
3.2. Evaluation on Synthetic Data
In the 5 sub-figures of Figure 3, we demonstrate that
NetAP can effectively detect cancer subtypes with respect to
weak and strong gene network structure. The comparison is
done with NMF, AP, LDA and NBS on synthetic data using
five evaluation metrics (NMF, RI, AR, Chi-square, P-value).
We run each algorithm 20 times, and all results of these five
metrics are the average value of 20 times per experimental
setting. NMF, LDA and AP, which are the three algorithms
that do not utilize gene interaction networks, in general, have
worse performance compared to NetAP and NBS, which are
the two algorithms using gene network information.
Furthermore, NetAP works robustly and is better than
NBS. By increasing the rate of overlapping from 0.05 to 0.1,
we find that the performance of all methods is worse due
to more noise in each clustering (the clustering membership
is less certain due to the increased overlap). NetAP remains
the best out of all these methods.
With Lung caner data, NetAP achieves the best perfor-
TABLE 3. PERFORMANCE OF NETAP AND OTHER CLUSTERING
METHODS ON UTERINE CANCER USING NMI.
K 3 4 5
Random 0.0138 0.0199 0.0245
SparseNMF 0.0247 0.0141 0.0198
Kmeans 0.0332 0.1035 0.1040
PAM 0.0136 0.0708 0.1073
Hierarchical 0.0107 0.0708 0.1073
NetAP 0.2659 0.2488 0.2473
mance compared to all other methods. However, although
NBS still outperforms NMF, it has similar performance with
AP that does not take advantage of gene network structure.
We suspect that NMF-based methods (NBS is based on
NMF) still struggle with extremely sparse data such as
somatic mutation data that has lots of 0s and few 1s, even
though that incorporating network information can help to
alleviate the spareness problem to a certain degree.
By analyzing the results of two real-world cancer
datasets, we found that AR of LDA and NMF are very close
to zero that is barely better than random assignment. In Table
3, we showed that the well-established clustering algorithm
SparseNMF (NMF using L1 regularization), Kmeans, PAM,
Hierarchical clustering algorithms have almost identical or
worse performance than random assignment.
In our work, we assume that cancer patients belonging to
one subtype are more likely to share a similar network subre-
gion. Network based NBS (also NMF based) achieves better
results than NMF, and NetAP outperforms all other methods
that we compared against in real-world data. Because NMF
and its variations do not work very well due to sparse and
heterogeneous characteristics of somatic mutation feature
space.
In summary, we can conclude that NetAP is the most
appropriate clustering algorithm for clustering gene muta-
tions. Because NBS and NetAP are the only two algorithms
using gene network, we will compare them in more details
using the other two gene networks.
We chose four existing methods (NMF, LDA, AP, NBS)
in the previous experiment. To fully assess the effective-
ness of our method, we have conducted more experiment
to compare with other clustering algorithms (SparseNMF
[24], Kmeans [17], PAM [25] and Hierarchical [26]). For
conciseness we only show the results using NMI metric.
”Random” refers to the result by random drawing. The
performance of these existing methods is very similar to the
results of ”Random”, which means all these methods are not
effective for somatic mutation stratification due to extreme
sparseness of somatic mutations. Therefore, incorporating
the knowledge of gene network to reduce sparseness is very
important for identifying subtypes from somatic mutation
data.
3.2.1. Impact of Gene Networks. Figure 5 shows the
performance of NetAP and NBS on the uterine cancer
dataset, incorporating the other two networks (STRING and
HumanNet) with different numbers of subtypes (K=3, 4, ...,
12) using five metrics (NMF, RI, AR, Chi-square, P-value).
Figure 4. Performance of NetAP compared to NMF, LDA, AP, and NBS
with different values of K using NMI, Rand index, Adjusted Rand Index,
Chi-square and P-value metrics on uterine and lung Cancer. NetAP is our
proposed method. For P-value, the smaller the better. For others, the larger
the better.
Clearly NetAP works better than NBS on these two gene
interaction networks in general, except on AR and RI met-
rics using the STRING network. Especially, when increasing
the number of subtypes K, NetAP can achieve better results
than NBS. The experimental results give further evidence
that our method is more robust for subtype identification.
As NetAP is naturally dependent on gene interaction
networks, we examine how different gene networks affect
the quality of NetAP with NMI metric. We chose the fol-
lowing three gene networks: PathwayCommons, STRING
and HumanNet. Figure 6 shows the results of NetAP with
different gene networks on uterine cancer dataset. When
varying the subtypes from 3 to 12, NetAP using Pathway-
Commons or STRING performs superior to NetAP using
HumanNet. Additionally, NetAP using PathwayCommons
outperforms NetAP using STRING. In conclusion, the per-
formance of NetAP will vary when it incorporates different
gene networks, because different network structures. The
new finding indicates that PathwayCommons can provide
strong genetic trait on cancer subtype discovery.
3.2.2. Identified Subtypes. To assess the biological signif-
icance of the identified subtypes, we examine whether they
correlate with observed clinical data. Figure 7 shows the re-
sults of NMF, LDA, AP, NetAP and NBS with the recorded
subtypes on a histological basis. We can see that NetAP sub-
types are more closely associated with the recorded subtypes
on the histological basis than other algorithms. NMF and
LDA cannot separate any type of ”serous adenocarcinoma
type” and ”endometrioid type” from the data set. NBS can
only extract one subtype ”serous adenocarcinoma type”.
NetAP and AP can separate the two subtypes ”serous ade-
nocarcinoma type” and ”endometrioid type”. Furthermore,
NetAP has higher accuracy than AP.
4. Related Work
Clustering is difficult because it belongs to unsupervised
learning and there does not always exist an unambiguous
membership for a data point. Many clustering algorithms
have been proposed to discover hidden structures for a
variety of applications [17], [27], [28]. Popular clustering
algorithms include K-means [17], its variation PAM [25],
Hierarchical clustering [26], DBSCAN [29], Latent dirichlet
allocation (LDA) [20], Hierarchical Dirichlet process [30],
Principal component analysis(PCA) [25] and Affinity Prop-
agation (AP) [14]. Based on whether data elements can
belong to one cluster or more than one cluster, clustering
algorithms can be categorized as hard clustering or soft
clustering. In hard clustering, data is divided into distinct
clusters, where each data element belongs to exactly one
cluster, e.g. K-means algorithm [25] and Affinity Propa-
gation (AP) [14]. In soft clustering (also referred to as
fuzz clustering), data elements can belong to more than
one cluster, and associated with each element is a set of
membership levels, e.g. Non-negative Matrix Factorization
(NMF) [19], [27] and Latent dirichlet allocation (LDA) [20],
[21].
Figure 5. Performance of NBS and NetAP on the other two human networks
(STRING and HumanNet) with respect to different values of K. For P-
value, the smaller the better. For others, the larger the better.
Figure 6. Performance of NetAP with three gene networks (Pathway-
Commons, STRING and HumanNet) using NMI on Uterine cancer.
If we focus on clustering algorithms to stratify sparse
and heterogeneous somatic mutational profiles, perhaps the
most popular approach for subtype discovery is NMF, which
does not require any priori knowledge of the expected
number of subtypes or the associated mutational patterns
[27]. NMF aims to find two non-negative matrices whose
product provides a good approximation to the original ma-
trix. One of its drawbacks is that it does not always result
in meaningful parts-based clustering representations. Several
researchers addressed this problem through incorporating
sparseness constraint (sparse NMF) on one or both non-
negative matrices [24], [31]. In addition, NetNMF, one of
NMF variants, encoded the geometrical structure in the data
to regularize one of the two non-negative matrices [32].
NMF has been applied to recover meaningful biological
information from cancer-related microarray data without
supervision [27], [33]. However even NMF with sparseness
constraints cannot effectively stratify somatic mutation data
because of its extremely sparseness. Since there are a variety
of gene interaction networks, Network-based stratification
(NBS) [7] adopted NetNMF algorithm for handling somatic
mutational profiles. So far, NBS is the only method to
stratify patients in an unsupervised fashion from somatic
mutation data. However, its performance still needs signif-
icant improvement for practical clinical application. With
high-dimensional sparse data the other natural choice is to
learn a low-dimensional representation using techniques like
Latent Semantic Indexing (LSI) [34] or Latent Dirichlet
Allocation (LDA) [20], however these methods often fail
to show any meaningful improvement on somatic mutation
clustering.
5. Conclusion
In this paper, we study the critical problem of stratifying
tumor mutation profiles into subtypes through incorporating
gene interaction information. We present a new frame-
work called Network-based Affinity Propagation (NetAP)
(a) NMF
(b) LDA
(c) AP
(d) NBS
(e) NetAP
Figure 7. Summary of Histological types for each subtype on Uterine
Cancer.
to cluster tumor mutations with gene networks. To use
the knowledge of the gene network, we project patient
profiles into a gene interaction network and develop a new
distance metric called gene aligning’s similarity to compute
the similarity between patients. We demonstrate the effec-
tiveness and efficiency of our approach on synthetic and
uterine adenocarcinoma datasets along with three popular
gene networks using five different metrics. In future, we plan
to integrate multiple layers of information beyond somatic
mutations (e.g. CNVs, transcriptome, etc.) into our method
for better subtype identification.
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